CPC Scientific

Official Entity • USA / China

CDMO specializing in large-scale, late-phase, and commercial GMP peptide and oligonucleotide manufacturing. Annual peptide API production capacity exceeds 1,000 kg. Serves clinical and commercial pharmaceutical clients. New US-based facility opening 2026. Maintains global shipping logistics for multi-kg batches.

Official Website Report Discrepancy

Verification Summary

ConfidenceHigh

Business TypeCDMO

ModelManufacturer

RegionGlobal

Founded2000

Verification status based on publicly available information and supplier-provided materials.

Products & Categories

Products

Catalog Peptides Custom Peptides Generic Peptides Peptide-Oligo Conjugates Oligonucleotides

Capabilities

Research Peptide Products Custom Synthesis Peptide APIs Oligonucleotides

Categories

CDMO pharmaceutical

Quality & Logistics

International Shipping In-House Production COAs Available Third-Party Tested

Verification Sources

Is this your company?

Claim this listing to update your information, respond to buyer inquiries, and get a verified badge.

Update your company details and products
Get a verified supplier badge
Receive buyer inquiries from our directory

Claim This Listing

Free to claim. Verified upgrades available.